SOURCE: Horizon Pharma

Horizon Pharma

May 02, 2012 07:30 ET

Horizon Pharma to Present at the 11th Annual JMP Securities Research Conference

DEERFIELD, IL--(Marketwire - May 2, 2012) - Horizon Pharma, Inc. (NASDAQ: HZNP) today announced that Timothy P. Walbert, chairman, president and chief executive officer, will present at the JMP Securities Research Conference on Monday, May 14, 2012 at 10:00 a.m. Pacific Time (1:00 p.m. Eastern time) in San Francisco, CA. Mr. Walbert will provide an overview of the Company and its corporate activities.

The presentation will be webcast live and may be accessed by visiting Horizon's website at A replay of the webcast will be available for 10 business days.

About Horizon Pharma
Horizon Pharma, Inc. is a biopharmaceutical company that is developing and commercializing innovative medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. For more information, please visit

Contact Information

  • Contacts
    Robert J. De Vaere
    Executive Vice President and Chief Financial Officer
    Email Contact

    Kathy Galante
    Burns McClellan, Inc.
    Email Contact